New Portfolio Strategy

Since starting investing years ago i have moved from barely tracking overall performance to annual reviews which attempt to track overall portfolio performance but this is hindered by the my various accounts, cash balances and leverages that have been used. My investing style was varied, entirely discretionary and ad-hoc. I would like to more clearly […]

Read More

2018 NAPS style portfolio update – there isn’t one!

I haven’t posted in a long time and have neglected to post a 2018 NAPS style model portfolio. I explained in my 2017 NAPSesque post that i was nervous about the market and wanted to stay partly in cash. The FTSE 350 actually ended the year c. 8% up whereas my portfolio which was 50% […]

Read More

NAPS 2017 – deciding to remain ‘in cash’

So i wrote a post with my NAPs for 2017 but being short of time, and on the whole nervous about the markets i didnt post it. I then resolved to post my NAPS on the basis that i’d be notionally 50% invested, holding the other 50% as cash until a point in the year […]

Read More

2016 NAPS Portfolio Performance

Time for a brief review of my 2016 NAPS performance …  overall a 17.8% gain. Not bad at all – not quite last years 24.2% gain but respectable nonetheless. Looking through the individual companies  a stop loss at circa 20% would have saved me from Genel and Fairpoint big losses but on the other hand […]

Read More

2016 ‘NAPS’ Selections

I’ve chosen a selection of ‘NAPS’ for 2016. To recap the idea being to see if my choice of companies (no changes allowed during the year) beats my personal portfolio by the end of the year and how it compares to the Stockopedia mechanical NAPS and FTSE/AIM indexes. I’m also hoping to establish over a long time frame […]

Read More

2015 ‘NAPS’ Portfolio Review

At the start of 2015, inspired by stockopedias ‘NAPs’ i put together a portfolio of companies i thought would do well in 2015 based on high stock ranks, recommendations from respected investors and my own research. It’s a fantasy fund but the idea being that i wouldn’t tinker, by or sell, but would measure performance […]

Read More